US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 137.940
  • +7.440+5.70%
Close Nov 27 16:00 ET
  • 138.220
  • +0.280+0.20%
Post 20:01 ET
13.18BMarket Cap89.57P/E (TTM)

Sarepta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sarepta Therapeutics Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
405.06M
467.17M
+62.11M
Beat Est.
+22.07%
+40.79%
+15.33%
EPS
-0.16
0.34
+0.50
Beat Est.
+65.01%
+173.91%
+311.31%
Analyst Rating
Strong Buy

Nov 27, 2024

Sarepta Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 708.957M--
--2024/Q4-- / 583.131M--
Nov 6, 20242024/Q3467.172M / 405.059M--
Aug 7, 20242024/Q2362.931M / 387.814M--
May 1, 20242024/Q1413.464M / 375.429M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 708.957M--
--2024/Q4-- / 583.131M--
Nov 6, 20242024/Q3467.172M / 405.059M--
Aug 7, 20242024/Q2362.931M / 387.814M--
May 1, 20242024/Q1413.464M / 375.429M--

Unlock Free Earnings Estimates

Sarepta Therapeutics Earnings Reports

  • Sarepta Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:09 ET

  • Sarepta Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:07 ET

  • Sarepta Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 1 16:07 ET

  • Sarepta Therapeutics | 10-K: FY2023 Annual Report

    Feb 28 16:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 27, 2024

    Strong Buy

    • Buy

      95.46%

    • Hold

      0.00%

    • Sell

      4.55%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data